Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Adam Czaplinski

Showing results (11-20 of 19) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 19 results.
Critical Care (London, England)|April 20, 2010
Inter-rater reliability of the Full Outline of UnResponsiveness score and the Glasgow Coma Scale in critically ill patients: a prospective observational studyMichael Fischer, Stephan Rüegg, Adam Czaplinski, et al.
Muscle & Nerve|February 22, 2008
ALSFRS and appel ALS scores: discordance with disease progressionAndrei Voustianiouk, Gregory Seidel, Janki Panchal, et al.
Annals of Neurology|January 26, 2005
IgM deposits on skin nerves in anti-myelin-associated glycoprotein neuropathyRaffaella Lombardi, Beat Erne, Giuseppe Lauria, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|January 15, 2016
Prolonged-release fampridine in multiple sclerosis: Improved ambulation effected by changes in walking patternBjörn Zörner, Linard Filli, Katja Reuter, et al.
Multiple Sclerosis Journal - Experimental, Translational and Clinical|October 13, 2023
Tolerability of subcutaneous ofatumumab with long-term exposure in relapsing multiple sclerosisJohn Kramer, Ralf Linker, David Paling, et al.
Multiple Sclerosis and Related Disorders|December 12, 2018
Patterns of care for Multiple Sclerosis in a setting of universal care access: A cross-sectional studyLaura Barin, Marco Kaufmann, Anke Salmen, et al.
CNS Neuroscience & Therapeutics|April 24, 2013
Recommendations for the use of prolonged-release fampridine in patients with multiple sclerosis (MS)Jana Lizrova Preiningerova, Ulf Baumhackl, Tunde Csepany, et al.
Der Nervenarzt|July 23, 2021
[Multiple sclerosis treatment consensus group (MSTCG): position paper on disease-modifying treatment of multiple sclerosis 2021 (white paper)]Heinz Wiendl, Ralf Gold, Thomas Berger, et al.
Therapeutic Advances in Neurological Disorders|August 23, 2021
Multiple Sclerosis Therapy Consensus Group (MSTCG): position statement on disease-modifying therapies for multiple sclerosis (white paper)Heinz Wiendl, Ralf Gold, Thomas Berger, et al.
Pageof 2

Showing results (11-20 of 19) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 19 results.
Critical Care (London, England)|April 20, 2010
Inter-rater reliability of the Full Outline of UnResponsiveness score and the Glasgow Coma Scale in critically ill patients: a prospective observational studyMichael Fischer, Stephan Rüegg, Adam Czaplinski, et al.
Muscle & Nerve|February 22, 2008
ALSFRS and appel ALS scores: discordance with disease progressionAndrei Voustianiouk, Gregory Seidel, Janki Panchal, et al.
Annals of Neurology|January 26, 2005
IgM deposits on skin nerves in anti-myelin-associated glycoprotein neuropathyRaffaella Lombardi, Beat Erne, Giuseppe Lauria, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|January 15, 2016
Prolonged-release fampridine in multiple sclerosis: Improved ambulation effected by changes in walking patternBjörn Zörner, Linard Filli, Katja Reuter, et al.
Multiple Sclerosis Journal - Experimental, Translational and Clinical|October 13, 2023
Tolerability of subcutaneous ofatumumab with long-term exposure in relapsing multiple sclerosisJohn Kramer, Ralf Linker, David Paling, et al.
Multiple Sclerosis and Related Disorders|December 12, 2018
Patterns of care for Multiple Sclerosis in a setting of universal care access: A cross-sectional studyLaura Barin, Marco Kaufmann, Anke Salmen, et al.
CNS Neuroscience & Therapeutics|April 24, 2013
Recommendations for the use of prolonged-release fampridine in patients with multiple sclerosis (MS)Jana Lizrova Preiningerova, Ulf Baumhackl, Tunde Csepany, et al.
Der Nervenarzt|July 23, 2021
[Multiple sclerosis treatment consensus group (MSTCG): position paper on disease-modifying treatment of multiple sclerosis 2021 (white paper)]Heinz Wiendl, Ralf Gold, Thomas Berger, et al.
Therapeutic Advances in Neurological Disorders|August 23, 2021
Multiple Sclerosis Therapy Consensus Group (MSTCG): position statement on disease-modifying therapies for multiple sclerosis (white paper)Heinz Wiendl, Ralf Gold, Thomas Berger, et al.
Pageof 2